Allelic and isotypic (haplotype) exclusion establishes that each B cell expresses only one immunoglobulin heavy and light chain pair and, consequently, exhibits a single specificity. Nevertheless, B cells expressing either two heavy or two light chains (haplotype-included) exist in healthy individuals and wild-type mice at a frequency estimated to be approximately 2-10% of the B cell population. Analyses of immunoglobulin transgenic mice have demonstrated that autoreactive B cells can sometimes bypass mechanisms of central tolerance by co-expressing non-autoreactive antigen receptors. These haplotype-included cells co-express autoreactive and non-autoreactive antigen receptors and are found in the mature B cell population. Because the majority of primary immunoglobulin gene rearrangements encode autoreactive specificities, we propose that wild-type haplotype-included B cells have higher chances of being autoreactive than haplotype-included (single Ab-expressing) B cells. The goal of this proposal is to understand the nature and regulation of haplotype-included B cells in mice and to determine if these cells are associated with autoimmunity. To accomplish this we outline three Specific Aims that will characterize dual immunoglobulin light chain- expressing B cells in mice with a wild-type antibody repertoire, determine whether these B cells contribute to the autoimmune process of autoimmune-prone mice, and understand how haplotype- included B cells are physiologically regulated. Haplotype-included autoreactive B cells will be evaluated both in vitro and in vivo using various mouse models and a variety of techniques that include the generation and characterization of B cell hybridomas and the use of cell adoptive transfer. Because autoimmunity is a significant health issue that has multiple, as of yet, poorly understood etiological bases, a molecular and cellular analysis of haplotype-included B lymphocytes is warranted. In particular, we predict haplotype-included B cells to be unique in that the autoantibody they express have the potential to exhibit a high avidity interaction with autoantigen and produce antibodies that simultaneously bind foreign as well as self-antigens. Project Narrative: Systemic autoimmune diseases such as lupus erythematosus and rheumatoid arthritis are complex disorders caused by defects in B and other blood cell types and that continue to cause significant morbidity and mortality. Although significant knowledge on these conditions has been achieved, substantial work remains to be done to fully understand the etiology and pathogenesis of these diseases. Some B cells in autoimmunity secrete autoantibodies that bind to molecules produced by the organism. It is still vastly unclear why these cells are generated and why they are activated to secrete autoantibodies. Our studies aim at characterizing a small population of B cells in mice that express two types of antibodies to determine whether these cells are progenitors of autoantibody-secreting cells and pathogenic players of autoimmunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052310-09
Application #
8239530
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Peyman, John A
Project Start
2002-07-01
Project End
2013-05-31
Budget Start
2012-04-01
Budget End
2013-05-31
Support Year
9
Fiscal Year
2012
Total Cost
$343,709
Indirect Cost
$114,929
Name
National Jewish Health
Department
Type
DUNS #
076443019
City
Denver
State
CO
Country
United States
Zip Code
80206
Bednarek, Joseph; Traxinger, Brianna; Brigham, Dania et al. (2018) Cytokine-Producing B Cells Promote Immune-Mediated Bile Duct Injury in Murine Biliary Atresia. Hepatology 68:1890-1904
Sang, Allison; Danhorn, Thomas; Peterson, Jacob N et al. (2018) Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun 9:3973
Agazio, Amanda E; Pelanda, Roberta; Torres, Raul M (2018) Silencing of TLM B cells by chronic HIV infection. Nat Immunol 19:902-903
Greaves, Sarah A; Peterson, Jacob N; Torres, Raul M et al. (2018) Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance. Front Immunol 9:707
Schroeder, Kristin M S; Agazio, Amanda; Strauch, Pamela J et al. (2017) Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies. J Exp Med 214:2283-2302
Lang, Julie; Zhang, Bicheng; Kelly, Margot et al. (2017) Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice. Blood Adv 1:2729-2741
Lang, Julie; Ota, Takayuki; Kelly, Margot et al. (2016) Receptor editing and genetic variability in human autoreactive B cells. J Exp Med 213:93-108
Hobeika, Elias; Levit-Zerdoun, Ella; Anastasopoulou, Vasiliki et al. (2015) CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk. EMBO J 34:925-39
Pelanda, Roberta (2014) Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity? Curr Opin Immunol 27:53-9
Hu, Jiancheng; Oda, Shannon K; Shotts, Kristin et al. (2014) Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol 193:85-95

Showing the most recent 10 out of 29 publications